Bravida Medical

Executive Summary

Bravida Medical, founded in 2018 and headquartered in San Jose, CA, is a private medical device company dedicated to transforming wound care and infection prevention. The company's portfolio features clinically proven, transformative products that offer uncompromising freedom and protection for patients. While specific financial details and stage are not publicly disclosed, Bravida's focus on a large and growing market—chronic wounds affect millions annually and infection prevention is a critical healthcare priority—positions it for significant impact. The company's technology likely includes advanced dressings, antimicrobial solutions, or wearable devices that improve patient outcomes and reduce healthcare costs. As a private entity, Bravida may be poised for strategic partnerships or commercialization milestones that could drive growth and attract investment.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for a novel wound dressing70% success
• Q2 2026Series B funding round closure80% success
• Q4 2026Publication of positive clinical trial results in a peer-reviewed journal60% success